Therapeutics Acquisition Corp.
Therapeutics Acquisition Corp. (RACA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RACA · as of Jun 9, 2026
Key Statistics
Explore Therapeutics Acquisition Corp. Data
raca stock data · financialsCompetitors & Peers
raca competitorsRACA
AMHC
DNAA
FGNA
HERA
HUMAStock Performance
Full HistoryAbout Therapeutics Acquisition Corp.
Therapeutics Acquisition Corp. which operates as Research Alliance Corp. I, was founded in 2020 and is headquartered in Boston, Massachusetts. Its core mission is to pursue a business combination, in…
what is therapeutics acquisition corp. · raca stock overview · therapeutics acquisition corp. company profile · who is therapeutics acquisition corp. ceo · raca NASDAQ · therapeutics acquisition corp. headquarters · therapeutics acquisition corp. business segments
About Stock Overview & Key Data
Therapeutics Acquisition Corp. (RACA) is a Financial Services company in the Shell Companies industry, listed on NASDAQ since Aug 7, 2020. As of the latest trading session, RACA stock price is $10.27, with a market capitalization of $1.1B. The stock has returned +59.54% over the past 12 months and +0.00% year-to-date.
Frequently Asked Questions
As of the latest trading session, Therapeutics Acquisition Corp. (RACA) stock price is $10.27. The stock is traded on NASDAQ under the ticker symbol RACA. The 52-week range is $10.00 – $10.33.